Lobbying client
INTERCEPT PHARMACEUTICALS
Pharmaceutical Company
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Filings
20
Filed by
2
Reported in-house
—
Reported by firms
$380,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2022 to 2026
Filings
20 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination 2nd Quarter 2024
|
AMERICAN CAPITOL GROUP | $30,000 reported |
|
1st Quarter - Report 1st Quarter 2024
|
AMERICAN CAPITOL GROUP | $30,000 reported |
|
4th Quarter - Report 4th Quarter 2023
|
AMERICAN CAPITOL GROUP | $30,000 reported |
|
3rd Quarter - Report 3rd Quarter 2023
|
AMERICAN CAPITOL GROUP | $30,000 reported |
|
2nd Quarter - Report 2nd Quarter 2023
|
AMERICAN CAPITOL GROUP | $30,000 reported |
|
1st Quarter - Report 1st Quarter 2023
|
AMERICAN CAPITOL GROUP | $30,000 reported |
|
4th Quarter - Report 4th Quarter 2022
|
AMERICAN CAPITOL GROUP | $30,000 reported |
|
3rd Quarter - Report 3rd Quarter 2022
|
AMERICAN CAPITOL GROUP | $30,000 reported |
|
2nd Quarter - Amendment 2nd Quarter 2022
|
AMERICAN CAPITOL GROUP | $20,000 reported |
|
Registration 2nd Quarter 2022
|
AMERICAN CAPITOL GROUP | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| AMERICAN CAPITOL GROUP | 9 | $260,000 |
| SIDLEY AUSTIN LLP | 9 | $120,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 13 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.